(Q40944812)

25 September 2017

title

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study (English)

1 reference

25 September 2017

1 reference

Sivi Ouwerkerk-Mahadevan

13

object named as

Sivi Ouwerkerk-Mahadevan

0 references

Beatriz Grinsztejn

6

object named as

Beatriz Grinsztejn

1 reference

25 September 2017

5

Andrzej Horban

1 reference

25 September 2017

3

Pierre-Marie Girard

1 reference

25 September 2017

Maria Luisa Montes

1

1 reference

25 September 2017

Mark Nelson

2

1 reference

25 September 2017

Joe Sasadeusz

4

1 reference

25 September 2017

Natalia Zakharova

7

1 reference

25 September 2017

Antonio Rivero

8

1 reference

25 September 2017

Jacques Durant

9

1 reference

25 September 2017

Enrique Ortega-Gonzalez

10

1 reference

25 September 2017

Erkki Lathouwers

11

1 reference

25 September 2017

Katrien Janssen

12

1 reference

25 September 2017

Sivi Ouwerkerk-Mahadevan

13

1 reference

25 September 2017

James Witek

14

1 reference

25 September 2017

Juan González-García

15

1 reference

25 September 2017

language of work or name

English

0 references

publication date

19 October 2015

1 reference

Journal of Antimicrobial Chemotherapy

25 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 September 2017

volume

71

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

244-250

1 reference

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Does HIV remain a risk factor for achieving sustained virologic response under direct acting antiviral-based modern hepatitis C virus therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Telaprevir for retreatment of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV323

21 January 2018

Identifiers

DOI

10.1093/JAC/DKV323

1 reference

25 September 2017

1 reference